Tanaka K - Search Results

1

Involvement of the osteoinductive factors, Tmem119 and BMP-2, and the ER stress response PERK-eIF2α-ATF4 pathway in the commitment of myoblastic into osteoblastic cells.

Tanaka K, Kaji H, Yamaguchi T, Kanazawa I, Canaff L, Hendy GN, Sugimoto T. Tanaka K, et al. Calcif Tissue Int. 2014 Apr;94(4):454-64. doi: 10.1007/s00223-013-9828-1. Epub 2013 Dec 22. Calcif Tissue Int. 2014. PMID: 24362451

2

FAM5C is a soluble osteoblast differentiation factor linking muscle to bone.

Tanaka K, Matsumoto E, Higashimaki Y, Sugimoto T, Seino S, Kaji H. Tanaka K, et al. Biochem Biophys Res Commun. 2012 Feb 3;418(1):134-9. doi: 10.1016/j.bbrc.2011.12.147. Epub 2012 Jan 8. Biochem Biophys Res Commun. 2012. PMID: 22245424

3

Role of osteoglycin in the linkage between muscle and bone.

Tanaka K, Matsumoto E, Higashimaki Y, Katagiri T, Sugimoto T, Seino S, Kaji H. Tanaka K, et al. J Biol Chem. 2012 Apr 6;287(15):11616-28. doi: 10.1074/jbc.M111.292193. Epub 2012 Feb 20. J Biol Chem. 2012. PMID: 22351757 Free PMC article.

4

Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.

Tanaka K, Inoue Y, Hendy GN, Canaff L, Katagiri T, Kitazawa R, Komori T, Sugimoto T, Seino S, Kaji H. Tanaka K, et al. Bone. 2012 Jul;51(1):158-67. doi: 10.1016/j.bone.2012.04.017. Epub 2012 May 2. Bone. 2012. PMID: 22579779

5

Partial improvement of anterior pituitary deficiency following steroid treatment in a patient with neurosarcoidosis accompanied by central diabetes insipidus.

Tanaka K, Yamamoto M, Okazaki K, Yamaguchi T, Sugimoto T. Tanaka K, et al. Intern Med. 2012;51(16):2175-9. doi: 10.2169/internalmedicine.51.6957. Epub 2012 Aug 15. Intern Med. 2012. PMID: 22892499 Free article.

6

Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis.

Okazaki K, Yamaguchi T, Tanaka K, Notsu M, Ogawa N, Yano S, Sugimoto T. Okazaki K, et al. Among authors: tanaka k. Calcif Tissue Int. 2012 Oct;91(4):286-96. doi: 10.1007/s00223-012-9641-2. Epub 2012 Aug 18. Calcif Tissue Int. 2012. PMID: 22903508

7

Hypercalcemia associated with eosinophilic myocarditis in a patient undergoing maintenance hemodialysis.

Tanaka K, Yano S, Okuyama K, Sato M, Yamauchi M, Yamaguchi T, Tanabe K, Himeno Y, Sugimoto T. Tanaka K, et al. Intern Med. 2012;51(20):2913-6. doi: 10.2169/internalmedicine.51.8227. Epub 2012 Oct 15. Intern Med. 2012. PMID: 23064567 Free article.

8

Fracture risk is increased by the complication of hypertension and treatment with calcium channel blockers in postmenopausal women with type 2 diabetes.

Takaoka S, Yamaguchi T, Tanaka K, Morita M, Yamamoto M, Yamauchi M, Yano S, Sugimoto T. Takaoka S, et al. Among authors: tanaka k. J Bone Miner Metab. 2013 Jan;31(1):102-7. doi: 10.1007/s00774-012-0389-6. Epub 2012 Oct 17. J Bone Miner Metab. 2013. PMID: 23073638 Clinical Trial.

9

Advanced glycation end products suppress osteoblastic differentiation of stromal cells by activating endoplasmic reticulum stress.

Tanaka K, Yamaguchi T, Kaji H, Kanazawa I, Sugimoto T. Tanaka K, et al. Biochem Biophys Res Commun. 2013 Aug 30;438(3):463-7. doi: 10.1016/j.bbrc.2013.07.126. Epub 2013 Aug 7. Biochem Biophys Res Commun. 2013. PMID: 23933252

10

One-hour post-load hyperglycemia by 75g oral glucose tolerance test as a novel risk factor of atherosclerosis.

Tanaka K, Kanazawa I, Yamaguchi T, Sugimoto T. Tanaka K, et al. Endocr J. 2014;61(4):329-34. doi: 10.1507/endocrj.ej13-0370. Epub 2014 Jan 16. Endocr J. 2014. PMID: 24430727 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,810 results

Search Page

Filters